Q. Yu

Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition

Kai Wang, Dewei Zhu, Yunhui Shen, 2022, Frontiers in Medicine.

chTLR4 pathway activation by Astragalus polysaccharide in bursa of Fabricius

Ruili Zhang, Xia Zhao, M. Ge, 2017, BMC Veterinary Research.

Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis

Yue Zhang, Xijuan Jiang, Yanrong Suo, 2022, Cardiology research and practice.

Two birds with one stone: YQSSF regulates both proliferation and apoptosis of bone marrow cells to relieve chemotherapy-induced myelosuppression.

Xijuan Jiang, Xiaolu Zhang, Qun Yu, 2022, Journal of ethnopharmacology.

Effectiveness of Combined Thrombolysis and Mild Hypothermia Therapy in Acute Cerebral Infarction: A Meta-Analysis

Maojuan Guo, Bin Yu, Huaien Bu, 2022, Evidence-based complementary and alternative medicine : eCAM.

Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesis

Maojuan Guo, Bin Yu, Xijuan Jiang, 2021, Immunity, inflammation and disease.

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)

Maojuan Guo, Xijuan Jiang, Lin-Po Yang, 2023, International journal of molecular medicine.

Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ

Qiuyue Yang, Maojuan Guo, Xijuan Jiang, 2023, Journal of Inflammation.

Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review)

Xijuan Jiang, Xiaolu Zhang, Qun Yu, 2022, International journal of molecular medicine.